AstraZeneca PLC (LON: AZN)
London
· Delayed Price · Currency is GBP · Price in GBX10,010
+41 (0.41%)
Nov 21, 2024, 10:45 AM BST
AstraZeneca Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 51,206 | 45,811 | 44,351 | 37,417 | 26,617 | 24,384 | Upgrade
|
| Revenue | 51,206 | 45,811 | 44,351 | 37,417 | 26,617 | 24,384 | Upgrade
|
| Revenue Growth (YoY) | 13.81% | 3.29% | 18.53% | 40.58% | 9.16% | 10.38% | Upgrade
|
| Cost of Revenue | 8,907 | 8,040 | 8,619 | 12,005 | 5,246 | 4,848 | Upgrade
|
| Gross Profit | 42,299 | 37,771 | 35,732 | 25,412 | 21,371 | 19,536 | Upgrade
|
| Selling, General & Admin | 18,081 | 18,025 | 17,422 | 14,673 | 11,586 | 11,438 | Upgrade
|
| Research & Development | 11,477 | 10,299 | 9,529 | 8,049 | 5,901 | 5,349 | Upgrade
|
| Other Operating Expenses | -932 | -987 | -231 | -207 | -486 | -319 | Upgrade
|
| Operating Expenses | 28,626 | 27,337 | 26,720 | 22,515 | 17,001 | 16,468 | Upgrade
|
| Operating Income | 13,673 | 10,434 | 9,012 | 2,897 | 4,370 | 3,068 | Upgrade
|
| Interest Expense | -1,351 | -1,219 | -917 | -776 | -738 | -780 | Upgrade
|
| Interest & Investment Income | 459 | 301 | 81 | 43 | 77 | 145 | Upgrade
|
| Earnings From Equity Investments | -23 | -12 | -5 | -64 | -27 | -116 | Upgrade
|
| Currency Exchange Gain (Loss) | -34 | -34 | -16 | -20 | -34 | -30 | Upgrade
|
| Other Non Operating Income (Expenses) | -292 | -292 | -370 | -478 | -487 | -542 | Upgrade
|
| EBT Excluding Unusual Items | 12,432 | 9,178 | 7,785 | 1,602 | 3,161 | 1,745 | Upgrade
|
| Merger & Restructuring Charges | -1,658 | -604 | -4,288 | -1,283 | -251 | -347 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | 776 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 51 | 292 | 216 | 509 | 1,055 | 1,222 | Upgrade
|
| Asset Writedown | -583 | -434 | -241 | -2,069 | -252 | -1,036 | Upgrade
|
| Legal Settlements | -1,013 | -1,013 | -789 | -48 | 9 | -610 | Upgrade
|
| Other Unusual Items | -1,307 | -520 | -182 | 248 | 194 | 574 | Upgrade
|
| Pretax Income | 7,922 | 6,899 | 2,501 | -265 | 3,916 | 1,548 | Upgrade
|
| Income Tax Expense | 1,422 | 938 | -792 | -380 | 772 | 321 | Upgrade
|
| Earnings From Continuing Operations | 6,500 | 5,961 | 3,293 | 115 | 3,144 | 1,227 | Upgrade
|
| Minority Interest in Earnings | -5 | -6 | -5 | -3 | 52 | 108 | Upgrade
|
| Net Income | 6,495 | 5,955 | 3,288 | 112 | 3,196 | 1,335 | Upgrade
|
| Net Income to Common | 6,495 | 5,955 | 3,288 | 112 | 3,196 | 1,335 | Upgrade
|
| Net Income Growth | 10.16% | 81.11% | 2835.71% | -96.50% | 139.40% | -38.05% | Upgrade
|
| Shares Outstanding (Basic) | 1,550 | 1,549 | 1,548 | 1,418 | 1,312 | 1,301 | Upgrade
|
| Shares Outstanding (Diluted) | 1,564 | 1,562 | 1,560 | 1,427 | 1,313 | 1,301 | Upgrade
|
| Shares Change (YoY) | 0.22% | 0.13% | 9.32% | 8.68% | 0.92% | 2.68% | Upgrade
|
| EPS (Basic) | 4.19 | 3.84 | 2.12 | 0.08 | 2.44 | 1.03 | Upgrade
|
| EPS (Diluted) | 4.15 | 3.81 | 2.11 | 0.08 | 2.44 | 1.03 | Upgrade
|
| EPS Growth | 9.79% | 80.57% | 2571.43% | -96.76% | 137.39% | -39.64% | Upgrade
|
| Free Cash Flow | 9,593 | 8,984 | 8,717 | 4,872 | 3,838 | 1,990 | Upgrade
|
| Free Cash Flow Per Share | 6.14 | 5.75 | 5.59 | 3.41 | 2.92 | 1.53 | Upgrade
|
| Dividend Per Share | 2.970 | 2.900 | 2.900 | 2.870 | 2.800 | 2.800 | Upgrade
|
| Dividend Growth | 2.41% | 0% | 1.05% | 2.50% | 0% | 0% | Upgrade
|
| Gross Margin | 82.61% | 82.45% | 80.57% | 67.92% | 80.29% | 80.12% | Upgrade
|
| Operating Margin | 26.70% | 22.78% | 20.32% | 7.74% | 16.42% | 12.58% | Upgrade
|
| Profit Margin | 12.68% | 13.00% | 7.41% | 0.30% | 12.01% | 5.47% | Upgrade
|
| Free Cash Flow Margin | 18.73% | 19.61% | 19.65% | 13.02% | 14.42% | 8.16% | Upgrade
|
| EBITDA | 18,391 | 15,010 | 13,944 | 6,701 | 6,990 | 5,575 | Upgrade
|
| EBITDA Margin | 35.92% | 32.77% | 31.44% | 17.91% | 26.26% | 22.86% | Upgrade
|
| D&A For EBITDA | 4,718 | 4,576 | 4,932 | 3,804 | 2,620 | 2,507 | Upgrade
|
| EBIT | 13,673 | 10,434 | 9,012 | 2,897 | 4,370 | 3,068 | Upgrade
|
| EBIT Margin | 26.70% | 22.78% | 20.32% | 7.74% | 16.42% | 12.58% | Upgrade
|
| Effective Tax Rate | 17.95% | 13.60% | - | - | 19.71% | 20.74% | Upgrade
|
| Revenue as Reported | 51,206 | 45,811 | 44,351 | 37,417 | 26,617 | 24,384 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.